home

Interview – Despite the many unknowns Celgene banks on CAR-T take-off

EVENTSepvantage2016-04-19 17:13 Read   68

Celgene is one of only two major drug  companies to make a big commitment to CAR-T, and its executives speak bullishly of the space.

San Diego Venture Funding Drops in QI—But Here are Top 10 Deals

EVENTSxconomy2016-04-19 17:02 Read   69

The pace of venture capital funding slowed substantially in San Diego during the first quarter, with venture firms investing $253.5 million in 21 startups, according to data from the MoneyTree Report.

Roche's first-quarter prescription drug sales climb 5 percent, lifted by cancer therapies

EVENTSfirstwordpharma2016-04-19 16:35 Read   98

Roche announced Tuesday that sales of prescription drugs in the first quarter rose 5 percent year-over-year to 9.8 billion Swiss francs ($10.2 billion), boosted by revenue from cancer drugs and immunology therapies.

UPDATED: J&J's Invokana under scrutiny in EU for potential link to toe amputations

EVENTSfiercepharma2016-04-19 13:31 Read   83

Johnson & Johnson’s ($JNJ) hot-selling Invokana has already come under scrutiny in the U.S. for safety issues, and now, it’s facing a new review across the pond. European regulators are sifting through data from a large ongoing clinical trial that showed an increase in toe amputations for patients taking the drug.

What's in a name? Plenty, if you're in the Merck vs. Merck trademark fight

EVENTSfiercepharma2016-04-19 13:24 Read   105

The Merck vs. Merck trademark spat just heated up with Germany-based Merck KGaA striking back at U.S.-based Merck & Co. with its own infringement allegations.

West Coast Biotech Roundup: Theranos, Medivation, Juno, and More

EVENTSxconomy2016-04-18 14:05 Read   68

Sean Parker, who made billions of dollars investing in Napster and Facebook, hosted a big party this week with Lady Gaga, John Legend, and a lot of movie stars.

Advent, Baxter preparing bids for India's Gland Pharma: sources

EVENTSreuters2016-04-18 13:51 Read   74

Global buyout firm Advent International and U.S.-based Baxter International (BAX.N) are among suitors preparing to submit separate bids to buy unlisted Indian drugmaker Gland Pharma Ltd, three people with direct knowledge of the matter told Reuters.

The looming threat of avian flu

EVENTSnytimes2016-04-18 13:47 Read   74

Even at a distance, it was obvious that there was something odd about the compost pile behind one of Brad Moline’s long white barns.

India M&A sees offshore interest in Gland Pharma

EVENTSfiercepharma2016-04-18 13:33 Read   75

Unlisted Hyderabad-based injectables maker Gland Pharma has drawn interest from outside India, including from Baxter International and Advent International of the U.S. for a company backed by of leveraged buyout firm KKR & Co.

Shire to expand biotechnology manufacturing capacity in Ireland

EVENTSidaireland2016-04-18 13:26 Read   73

Investment to help meet growing demand for rare disease treatments Expected to create 400 jobs in Ireland at new state-of-the-art facility in Co. Meath

Crestor Developer Sees Sales Doubling On Lower-Priced Drugs

EVENTSbloomberg2016-04-18 12:33 Read   69

Across the pharmaceutical industry, companies have rushed towards medicines with sky-high prices -- making bets in lucrative areas like complex cancer treatments and even gene therapy that could come with a $1 million price tag.

Exclusive: Valeant calls in investment banks to weigh options - sources

EVENTSreuters2016-04-18 11:39 Read   65

Valeant Pharmaceuticals International Inc (VRX.TO) has brought in investment banks to review its options amid interest from buyout firms and other companies in a number of its businesses, according to people familiar with the matter.